Effects of naturally occurring mutations in CUB-1 domain on synthesis, stability, and activity of ADAMTS-13.

INTRODUCTION Upon stimulation, endothelial cells release von Willebrand factor (VWF) in the unusually large (UL) and hyperactive forms that are rapidly cleaved by ADAMTS-13. Mutations in the ADAMTS13 gene result in ULVWF-mediated thrombosis found in patients with familial thrombotic thrombocytopenia purpura (TTP). ADAMTS-13 fits in the consensus of the ADAMTS family metalloproteases, but also contains two unique C- terminal CUB domains. Studying mutations in CUB domains could provide insights into the functional role of these domains. METHODS Three naturally occurring mutations (C1213Y, W1245del and K1256FS) in the CUB-1 domain found in patients with TTP were expressed in Hela cells. The secretion, stability and VWF-cleaving activity of the mutants under static and flow conditions were examined. RESULTS The mutations impaired secretion of ADAMTS-13 to apical surface, but not to extracellular matrix of transfected Hela cells. C1213Y and K1256FS also accelerated, whereas W1245del delayed, extracellular degradation of the mutants. The mutations also resulted in a moderate decrease in cleaving plasma VWF under static conditions. However, the mutated ADAMTS-13 bound to VWF substrate similarly as the wild-type metalloprotease and remained active in cleaving (UL)VWF under flow conditions. CONCLUSIONS The CUB-1 domain is critical for ADAMTS-13 secretion and stability upon secretion. ADAMTS-13 deficiency found in TTP patients could be resulted from reduced ADAMTS-13 secretion and, in the case of C1213Y and K1256FS accelerated degradation. W1245del is highly resistant to degradation and active in cleaving VWF.

[1]  B. Hoppe,et al.  Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS). , 2004, Kidney international.

[2]  K. Fujikawa,et al.  Structure of von Willebrand Factor-cleaving Protease (ADAMTS13), a Metalloprotease Involved in Thrombotic Thrombocytopenic Purpura* , 2001, The Journal of Biological Chemistry.

[3]  T. Foroud,et al.  Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura , 2001, Nature.

[4]  J. Moake,et al.  Platelet‐derived VWF‐cleaving metalloprotease ADAMTS‐13 , 2005, Journal of thrombosis and haemostasis : JTH.

[5]  Y. Okada,et al.  Detection of von Willebrand factor-cleaving protease (ADAMTS-13) in human platelets. , 2004, Biochemical and biophysical research communications.

[6]  B. Sachais,et al.  The cooperative activity between the carboxyl-terminal TSP1 repeats and the CUB domains of ADAMTS13 is crucial for recognition of von Willebrand factor under flow. , 2007, Blood.

[7]  Kazuo Fujikawa,et al.  ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. , 2002, Blood.

[8]  Sanjeev Gupta,et al.  ADAMTS13 is expressed in hepatic stellate cells , 2005, Laboratory Investigation.

[9]  J. Moake,et al.  Human endothelial cells synthesize and release ADAMTS‐13 , 2006, Journal of thrombosis and haemostasis : JTH.

[10]  L. P. Van den Heuvel,et al.  Mutation analysis and clinical implications of von Willebrand factor-cleaving protease deficiency. , 2003, Kidney international.

[11]  B. Lämmle,et al.  Recovery and Half-Life of von Willebrand Factor-Cleaving Protease after Plasma Therapy in Patients with Thrombotic Thrombocytopenic Purpura , 1999, Thrombosis and Haemostasis.

[12]  J. Sadler,et al.  Binding of ADAMTS13 to von Willebrand Factor* , 2005, Journal of Biological Chemistry.

[13]  J. Calvete,et al.  The crystal structures of two spermadhesins reveal the CUB domain fold , 1997, Nature Structural Biology.

[14]  A. Bernardo,et al.  Cleavage of ultralarge multimers of von Willebrand factor by C-terminal-truncated mutants of ADAMTS-13 under flow. , 2005, Blood.

[15]  X. Zheng,et al.  Apical sorting of ADAMTS13 in vascular endothelial cells and Madin-Darby canine kidney cells depends on the CUB domains and their association with lipid rafts. , 2006, Blood.

[16]  J. Voorberg,et al.  Antibodies against the CUB1-2 domains of ADAMTS13 in a patient with benign monoclonal gammopathy: no causal relationship. , 2007, Haematologica.

[17]  Toshio Mori,et al.  Localization of ADAMTS13 to the stellate cells of human liver. , 2005, Blood.

[18]  J. Moake,et al.  Novel ADAMTS‐13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura , 2006, Journal of thrombosis and haemostasis : JTH.

[19]  J. Moake,et al.  Recombinant CUB-1 domain polypeptide inhibits the cleavage of ULVWF strings by ADAMTS13 under flow conditions. , 2005, Blood.

[20]  X. Zheng,et al.  Inhibitory autoantibodies against ADAMTS‐13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS‐13 protease and may accelerate its clearance in vivo , 2006, Journal of thrombosis and haemostasis : JTH.

[21]  H. Tsai Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. , 1996, Blood.

[22]  E. Bouhassira,et al.  Enzymatically Active ADAMTS13 Variants Are Not Inhibited by Anti-ADAMTS13 Autoantibodies , 2005, Journal of Biological Chemistry.

[23]  J. Pimanda,et al.  Congenital thrombotic thrombocytopenic purpura in association with a mutation in the second CUB domain of ADAMTS13. , 2004, Blood.

[24]  J. Sadler,et al.  Cleavage of von Willebrand Factor Requires the Spacer Domain of the Metalloprotease ADAMTS13* , 2003, Journal of Biological Chemistry.